Objective: To investigate the population-based interaction between a biological variable (APOE e4), neuropsychiatric symptoms, and the risk of incident dementia among subjects with prevalent mild cognitive impairment (MCI).
Methods:We prospectively followed 332 participants with prevalent MCI (aged 70 years and older) enrolled in the Mayo Clinic Study of Aging for a median of 3 years. The diagnoses of MCI and dementia were made by an expert consensus panel based on published criteria, after reviewing neurologic, cognitive, and other pertinent data. Neuropsychiatric symptoms were determined at baseline using the Neuropsychiatric Inventory Questionnaire. We used Cox proportional hazards models, with age as a time scale, to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). Models were adjusted for sex, education, and medical comorbidity.Results: Baseline agitation, nighttime behaviors, depression, and apathy significantly increased the risk of incident dementia. We observed additive interactions between APOE e4 and depression (joint effect HR 5 2.21; 95% CI 5 1.24-3.91; test for additive interaction, p , 0.001); and between APOE e4 and apathy (joint effect HR 5 1.93; 95% CI 5 0.93-3.98; test for additive interaction, p 5 0.031). Anxiety, irritability, and appetite/eating were not associated with increased risk of incident dementia.Conclusions: Among prevalent MCI cases, baseline agitation, nighttime behaviors, depression, and apathy elevated the risk of incident dementia. There was a synergistic interaction between depression or apathy and APOE e4 in further elevating the risk of incident dementia. Dementia is one of the leading causes of morbidity and mortality in late life. It presents several challenges, not least of which are the economic consequences.1 Therefore, it is critical to prevent or delay dementia.2 Identification of high-risk groups is a key step toward the prevention of dementia. Mild cognitive impairment (MCI) is the intermediate stage between cognitive aging and dementia and is associated with an increased risk of dementia. Clinic-based samples have indicated that neuropsychiatric symptoms in prevalent MCI increase the risk of incident dementia.4-6 However, only a few studies were derived from population-based settings. 7,8 In addition, studies derived from clinical samples including our own team have reported the synergistic interaction between a neuropsychiatric symptom (e.g., depression) and APOE e4 in increasing the risk of incident dementia.
9-11While APOE e4 and neuropsychiatric symptoms are independent risk factors for incident dementia, little is known about the interaction between APOE e4 and a broad spectrum of neuropsychiatric symptoms in increasing the risk of incident dementia in a population-based